Biotechs are incredibly risky. They can shoot up or down 300-400% overnight! Very volatile. With that being said, I still plan to pick up more shares of Frequency Therapeutics before they announce their phase 2 results. Been following them for a long time and trust their leadership.
Whatever DID happen to that guy? Maybe he got bitten by the sea anemone he was trying to shove down his ears. LOL.
16 kHz is pretty impressive. I'm only 33 and my good ear tops out at 14 kHz. The bad at 12 kHz.
Let's hope it pans out, and it actually can help people. It's nice to see slightly promising results, but this isn't the first drug for hearing loss or tinnitus that's made it to phase 2. Statistically speaking this is still almost definitely going to fail.
Hi,
AM-101 (Keyzilen) was given Fast Track status, and it failed.
No , not any drug which have had " FDAfast tracking status", your words.
Wrong. It REALLY failed TWICE in phase 3 trials, and they always continued by changing the outcome endpoints.
There's research that just loud sounds with little to no hearing loss alone might be enough to trigger it. Dr. Shore looks into this in her research.
Right, people go to college to learn how to talk like this in front of cameras. I know because when I was in grad school I paid my tuition by working in the college's TV Film Radio degree program.
That's possible. It's also possible it's not. You don't know.
Actually, I do know, I recognize a professional actor when I see one, too many choreographed moves, no hesitation in the talking pattern, over exaggerated, unnatural emotions...
Just look at the 5 year price history of the Auris Medical stock, EARS, and it will be clear that they have not succeeded yet!
I can see her read, and I can see how she emphasizes what she's saying emotionally, but that doesn't mean an actor. They could've taken someone who wanted to share their story and worked with them to do that. That could've been take 25.
Member
